Ledger.Open graph →
SEC Form D · filed May 6, 2020

Evofem Biosciences, Inc

Offering
$25.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Lisa A. Rarick · San Diego, CADirectorColin Rutherford · San Diego, CADirectorAlexander A. Fitzpatrick · San Diego, CAExecRussell J. Barrans · San Diego, CAExecGillian Greer · San Diego, CADirectorTony P. O'Brien · San Diego, CADirectorSaundra Pelletier · San Diego, CAExec · DirectorKelly J. Culwell · San Diego, CAExecWilliam P. Hall · San Diego, CADirectorJustin J. File · San Diego, CAExecKim P. Kamdar · San Diego, CADirectorJohn H. Garrett, Iv · NEW YORK, NYExecBarry R. Stoler · Rockville, MDExecJeffery S. Potter · Aurora, COExec · DirectorB. Riley Capital Management, LLC · Los Angeles, CADirectorJarrod S. Deverse · Greenwood Village, CODirectorDonald C. Young · NEW YORK, NYDirectorJamie H. Kudrako · NEW YORK, NYDirectorDaniel A. Cohn · Arvada, CODirectorBRC Emerging Managers GP, LLC · Los Angeles, CAExecBrian C. Dilaura · San Francisco, CAExecMichael F. Salem · NEW YORK, NYDirectorKurt Skifstad · ANN ARBOR, MIExecChristian Birkmeyer · ANN ARBOR, MIDirectorAnthony Grover · ANN ARBOR, MIDirectorDavid A. Chan · San Francisco, CADirectorArtem Milinchuk · San Francisco, CAExec · DirectorDavid F. Randell · NEW YORK, NYDirectorAlison J. Rosenzweig · NEW YORK, NYExecCasey D. Whalen · NEW YORK, NYExecJerome C. Antenen · NEW YORK, NYDirectorJohn R. Warren · San Francisco, CAExecKevin J. Alerding · Indianapolis, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗